Neurogene Inc. (NGNE) Short Interest
Nasdaq • NGNE • US64135M1053
As of Oct 23, 2026, ORTEX estimated 43.8% of free float sold short, 15.5 days to cover, cost to borrow 0.39%. Sign up for live short interest data.
Nasdaq • NGNE • US64135M1053
As of Oct 23, 2026, ORTEX estimated 43.8% of free float sold short, 15.5 days to cover, cost to borrow 0.39%. Sign up for live short interest data.
This page tracks how heavily Neurogene Inc. (Nasdaq:NGNE) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Neurogene Inc. (Nasdaq: NGNE) has a market capitalization of $520.3M. Last close $26.00 (as of 2026-11-10); 52-week range $15.93 to $43.66. ORTEX data as of 2026-10-23: short interest was 43.79% of free float, 15.5 days to cover and the average cost to borrow was 0.39%. Sign up for live short interest data.